Research Article
Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway
Figure 5
Alisertib significantly enhances the antiproliferative and proapoptotic activities of lenvatinib in HCC cells in vivo. Images of control, alisertib-, lenvatinib- and alisertib-lenvatinib combination-treated tumor-bearing mice. (b) Images of subcutaneous xenograft tumors. (c) Changes in mouse body weights during the formation of subcutaneous xenograft tumors. (d) The growth curves of the subcutaneous xenograft tumors. (e) Representative images of H&E staining and TUNEL staining. and . Data are expressed as the . All experiments were repeated at least three times.
(a) |
(b) |
(c) |
(d) |
(e) |